Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dacarbazine

View Patient Information

A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	Biocarbazine Dacarbazina Dacarbazina Almirall Dacarbazine - DTIC Dakarbazin dimethyl (triazeno) imidazolecarboxamide dimethyl triazeno imidazol carboxamide dimethyl triazeno imidazole carboxamide dimethyl-triazeno-imidazole carboxamide dimethyl-triazeno-imidazole-carboximide imidazole carboxamide imidazole carboxamide dimethyltriazeno
Foreign brand name:	Asercit Dacatic Deticene Detimedac Fauldetic
Abbreviation:	DIC DTIC
Code name:	WR-139007
Chemical structure:	1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)- 5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide 5-(dimethyltriazeno)imidazole-4-carboxamide 5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide